LBelSupremacie Mains (VENTURA INTERNATIONAL LTD.,)
Welcome to the PulseAid listing for the LBel drug offered from VENTURA INTERNATIONAL LTD.,. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | VENTURA INTERNATIONAL LTD., |
NON-PROPRIETARY NAME: | Ensulizole, Octinoxate, and Oxybenzone |
SUBSTANCE NAME: | ENSULIZOLE; OCTINOXATE; OXYBENZONE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | CREAM |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2010-08-15 |
END MARKETING DATE: | 0000-00-00 |
LBel Supremacie Mains HUMAN OTC DRUG Details:
Item Description | LBel Supremacie Mains from VENTURA INTERNATIONAL LTD., |
LABELER NAME: | VENTURA INTERNATIONAL LTD., |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | .15; .38; .31(g/5mL; g/5mL; g/5mL) |
START MARKETING DATE: | 2010-08-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 14783-062_f9c27f44-9167-439a-a8bf-0280eabe477e |
PRODUCT NDC: | 14783-062 |
APPLICATION NUMBER: | part352 |
Other ENSULIZOLE; OCTINOXATE; OXYBENZONE Pharmaceutical Manufacturers / Labelers: